Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs031210540
JPRN-jRCTs031210540
Active, not recruiting
未知

Development of Diagnostic Imaging of Malignant Tumor using New PET Probe [11C] AIB

Tamura Kentaro0 sites10 target enrollmentJanuary 6, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMalignant neoplasmsD009369

Overview

Phase
未知
Intervention
Not specified
Conditions
Malignant neoplasms
Sponsor
Tamura Kentaro
Enrollment
10
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 6, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Healthy male subjects aged 20 or older and under 65 at the time of informed consent
  • •2\. Subjects who provide written informed consent
  • •3\. Subjects with BMI of less than 25

Exclusion Criteria

  • •1\. Subjects who have severe or progressive complications.
  • •2\. Subjects who have obvious abnormalities in physical and laboratory examinations after obtaining the informed consent
  • •3\. Subjects who have past history of severe drug hypersensitivity
  • •4\. Subjects with drug or alcohol addiction
  • •5\. Subjects who smoke
  • •6\. Subjects who have received medication or used vitamins, herbal medicines, or supplements within 14 days prior to their visit
  • •7\. Subjects who are claustrophobic
  • •8\. Subjects who have undergone an examination with radiation exposure for the purpose of medical treatment (X\-ray, CT, PET, DEXA, etc.) within the past 12 months, or for the purpose of research within the past 6 months. Chest X\-rays conducted as part of the annual medical check are excluded.
  • •9\. Subjects who are considered to be inappropriate to participate in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Development of the tumor-specific imaging technique on targeting amino acid transporterHealthy subjects, Brain tumor patients
JPRN-UMIN000015271Osaka City University Graduate School of Medicine40
Recruiting
Not Applicable
Development of imaging biomarkers based on tumor microenvironment for personalized treatment planning of peritoneal metastasis/recurrence in advanced gastric cancerNeoplasms
KCT0007302Soon Chun Hyang University240
Recruiting
Not Applicable
Histopathologic imaging of human cancer tissues using confocal microscopyNeoplasms
KCT0003818CC Hospital25
Completed
Not Applicable
Implementation of an imaging approach for diagnosis after finger amputatioS68S58Traumatic amputation of wrist and handTraumatic amputation of forearm
DRKS00025426BG Klinik Ludwigshafen, Klinik für Hand-, Plastische und Rekonstruktive Chirurgie - Schwerbrandverletztenzentrum8
Active, not recruiting
Not Applicable
Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CTpatients with prostate cancer istologically provenMedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2008-003337-24-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA